UBS Group’s CAS Medical Systems, Inc. CASM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-2,000
| Closed | -$5K | – | 8478 |
|
|
2019
Q1 | $5K | Sell |
2,000
-6,833
| -77% | -$14.7K | ﹤0.01% | 7228 |
|
|
2018
Q4 | $14K | Buy |
8,833
+4,270
| +94% | +$7.96K | ﹤0.01% | 7074 |
|
|
2018
Q3 | $11K | Buy |
4,563
+2,563
| +128% | +$5.47K | ﹤0.01% | 7146 |
|
|
2018
Q2 | $4K | Sell |
2,000
-5,095
| -72% | -$7.6K | ﹤0.01% | 7600 |
|
|
2018
Q1 | $9K | Sell |
7,095
-856
| -11% | -$965 | ﹤0.01% | 6973 |
|
|
2017
Q4 | $7K | Buy |
7,951
+4,673
| +143% | +$3.42K | ﹤0.01% | 7270 |
|
|
2017
Q3 | $3K | Sell |
3,278
-8,786
| -73% | -$9K | ﹤0.01% | 7427 |
|
|
2017
Q2 | $14K | Buy |
12,064
+10,064
| +503% | +$11.5K | ﹤0.01% | 6569 |
|
|
2017
Q1 | $3K | Sell |
2,000
-9,479
| -83% | -$14.4K | ﹤0.01% | 7234 |
|
|
2016
Q4 | $18K | Buy |
11,479
+6,876
| +149% | +$11.6K | ﹤0.01% | 6598 |
|
|
2016
Q3 | $8K | Buy |
+4,603
| New | +$7.99K | ﹤0.01% | 6941 |
|
|
2016
Q1 | – | Sell |
-3,649
| Closed | -$6K | – | 8495 |
|
|
2015
Q4 | $6K | Buy |
3,649
+2,042
| +127% | +$2.88K | ﹤0.01% | 7647 |
|
|
2015
Q3 | $2K | Sell |
1,607
-746
| -32% | -$882 | ﹤0.01% | 8131 |
|
|
2015
Q2 | $3K | Sell |
2,353
-6,070
| -72% | -$7.88K | ﹤0.01% | 8111 |
|
|
2015
Q1 | $11K | Buy |
8,423
+2,826
| +50% | +$4.07K | ﹤0.01% | 7596 |
|
|
2014
Q4 | $9K | Buy |
+5,597
| New | +$9.89K | ﹤0.01% | 8521 |
|
UBS Group's CASM Position: Q2 2019 in Review
UBS Group sold out of CAS Medical Systems, Inc. (CASM) in Q2 2019, closing a stake of 2,000 shares — an estimated $5K sold.
UBS Group first reported a position in CASM in Q4 2014 and held it in 16 quarters. The position peaked at $18K in Q4 2016. 0 funds tracked by Wall St. Rank hold CASM as of Q2 2019.
- UBS Group reported no remaining CAS Medical Systems, Inc. position as of Q2 2019 after selling out during the quarter.
- UBS Group sold 2,000 CAS Medical Systems, Inc. shares in Q2 2019, an estimated $5K.
- UBS Group first reported a position in CAS Medical Systems, Inc. in Q4 2014 and held it in 16 quarters.
- UBS Group's CAS Medical Systems, Inc. position peaked at $18K in Q4 2016.
- 0 funds tracked by Wall St. Rank held CAS Medical Systems, Inc. as of Q2 2019.
Based on UBS Group's 13F filing for Q2 2019, filed 14 Aug 2019.